Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the study is to determine whether topical ocular administration of LME636 60 mg/mL is efficacious in resolving the ocular inflammation in the anterior chamber (AC) associated with acute anterior uveitis (AAU).
Epistemonikos ID: e883f05c5de4be2894f07f2ae767fc5dfad3fce9
First added on: May 12, 2024